Novartis AG
Polyomavirus neutralizing antibodies

Last updated:

Abstract:

The present invention relates to anti-polyomavirus antibodies, antibody fragments, and their uses for the prevention and treatment of BK or JC virus infection and associated diseases.

Status:
Grant
Type:

Utility

Filling date:

28 Nov 2018

Issue date:

6 Sep 2022